Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
eye irritation: in vitro / ex vivo
Type of information:
experimental study
Adequacy of study:
key study
Study period:
29 June 2020
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2020
Report date:
2020

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 438 (Isolated Chicken Eye Test Method for Identifying i) Chemicals Inducing Serious Eye Damage and ii) Chemicals Not Requiring Classification for Eye Irritation or Serious Eye Damage)
Version / remarks:
25 June 2018
Deviations:
no
Principles of method if other than guideline:
On request of the sponsor, an additional classification is made with the scheme of Schutte et al (2009), Regulatory Toxicology and Pharmacology 54.
GLP compliance:
yes (incl. QA statement)
Remarks:
d.d. 03 August 2018

Test material

1
Chemical structure
Reference substance name:
[2,2-bis[(3,7-dimethyl-2,6-octadienyl)oxy]ethyl]benzene
EC Number:
266-805-6
EC Name:
[2,2-bis[(3,7-dimethyl-2,6-octadienyl)oxy]ethyl]benzene
Cas Number:
67634-02-0
Molecular formula:
C28H42O2
IUPAC Name:
(2,2‐bis(((E)‐3,7‐dimethylocta‐2,6‐dien‐1‐yl)oxy)ethyl)benzene
Test material form:
liquid

Test animals / tissue source

Species:
chicken
Strain:
other: ROSS 308
Details on test animals or tissues and environmental conditions:
SOURCE OF COLLECTED EYES
- Source: TARAVIS KFT. (Address: H-9600 Sárvár, Rábasömjéni utca 129., Hungary)
- Storage, temperature, and transport conditions of ocular tissue: Chicken heads (7 weeks old) were collected and transported to the test site at ambient temperature at the earliest convenience. The heads were received at test site and were processed within 2 hours of collection.

Test system

Vehicle:
unchanged (no vehicle)
Controls:
yes, concurrent positive control
yes, concurrent negative control
Amount / concentration applied:
TEST MATERIAL
- Amount applied: 30 µL per cornea.

POSITIVE CONTROL
- Amount applied: 30 µL per cornea.
- This material was mixed with distilled water to achieve the final concentration of 5% (w/v). The treatment solution was prepared immediately before the experiment.

NEGATIVE CONTROL
- Amount applied: 30 µL per cornea.
Duration of treatment / exposure:
10 seconds
Duration of post- treatment incubation (in vitro):
240 minutes
Number of animals or in vitro replicates:
3 replicates for the positive and treatment group each and one for the negative group
Details on study design:
SELECTION AND PREPARATION OF ISOLATED EYES
The eyeball was carefully removed from the orbit by holding the nictitating membrane with a surgical forceps, while cutting the eye muscles with bent scissors. Care was taken to remove the eyeball from the orbit without cutting off the optical nerve too short. The procedure avoided pressure on the eye while removing the eyeball from the orbit, in order to prevent distortion of the cornea and subsequent corneal opacity. Once removed from the orbit, the eye was placed onto damp paper and the nictitating membrane was cut away with other connective tissue. The prepared eyes were kept on the wet papers in a closed box so that the appropriate humidity was maintained.
Eyes were examined with slit lamp microscope to ensure that they were in good condition. The focus was adjusted to see clearly the physiological saline which was flowing on the cornea surface. Eyes with a high baseline fluorescein staining (i.e., > 0.5) or corneal opacity score (i.e., > 0.5) were rejected. The cornea thickness was measured, any eye with cornea thickness deviating more than 10 % from the mean value for all eyes, or eyes that showed any other signs of damage, were rejected and replaced. If the selected eyes were appropriate for the test, acclimatization started and it was conducted for approximately 45 to 60 minutes. The chambers of the superfusion apparatus were at controlled temperature (32±1.5°C) during the acclimatization and treatment periods.

EQUILIBRATION AND BASELINE RECORDINGS
At the end of the acclimatization period, a zero reference measurement was recorded for cornea thickness and opacity to serve as a baseline (t=0) for each individual eye. The cornea thickness of the eyes should not change by more than 5% within the -45 min and the zero time. No significant corneal thickness changes (-1.6% was observed in one eye) and no corneal thickness changes were observed in the other eyes. Following the equilibration period, the fluorescein retention was measured. Baseline values were required to evaluate any potential test item related effect after treatment. All eyes were considered to be suitable for the assay

ADMINISTRATION OF TEST AND CONTROL ITEMS
After the zero reference measurements, the eye in its retainer was taken out of the chamber and placed on a layer of tissue with the cornea facing upwards. The eye was held in horizontal position, while the test material was applied onto the centre of the cornea. 30 μL of the test item was applied onto the entire surface of the cornea attempting to cover the cornea surface uniformly with the test item, taking care not to damage or touch the cornea. The positive and negative control eyes were treated in a similar way.

REMOVAL OF TEST SUBSTANCE
After an exposure period of 10 seconds the cornea surface was rinsed thoroughly with 20 mL physiological saline solution at ambient temperature to remove all residual test material without damaging the eyes. The solubility of the test item in physiological saline was tested prior to the experiment, the test item did not dissolve in physiological saline.

OBSERVATION PERIOD
-Corneal thickness and corneal opacity: Pre- treatment and at approximately (±5 minutes) 30, 75, 120, 180 and 240 minutes after the post-treatment rinse
-Fluorescein retention: Pre- treatment and at approximately (±5 minutes) 30 minutes after the post-treatment rinse

METHODS FOR MEASURED ENDPOINTS:
- Corneal swelling: An optical pachymeter on a slit lamp microscope
- Corneal opacity: slit lamp microscope
- Fluorescein retention: slit lamp microscope

SCORING SYSTEM:
- Mean corneal swelling (%):
corneal swelling (t) = (cornea thickness (t) – cornea thickness at t=0) / (cornea thickness at t=0) x 100
Mean corneal swelling (t) = (1st eye corneal swelling (t)+ 2nd eye corneal swelling (t) +3rd eye corneal swelling (t)) /3

For the calculation of maximum corneal swelling, small negative numbers for swelling following application (0 to -5%) are counted as zero (scored as class I). Large negative numbers (>12% below control) are probably due to erosion and indicate a severe effect (scored as class IV). Cases of values of -5% to -12% are evaluated on a case by case basis but in the absence of other findings do not indicate a severe effect (class II).

- Mean maximum opacity score:
Δcornea opacity (t) = cornea opacity (t) – cornea opacity at t=0
Mean Δcornea opacity (max) = 1st eye cornea opacity max(30min to 240min)+ 2nd cornea opacity eye max(30min to 240min) + 3rd eye cornea opacity max(30min to 240min) /3

- Mean fluorescein retention score at 30 minutes post-treatment:
Δfluorescein retention(t) = fluorescein retention (t) – fluorescein retention at t=0
Mean Δfluorescein retention = (1st eye fluorescein retention (30min) + 2nd eye fluorescein retention (30min) + 3rd eye fluorescein retention (30min)) /3

DECISION CRITERIA: The mean maximum corneal swelling up to 75 or 240 min, the mean maximum corneal opacity and the mean fluorescein retention change were assinged ICE classes which are used for classification according to UN GHS (2018) criteria or Schutte et al (2009) criteria. (see Tables 1 t/m 7)

Results and discussion

In vitro

Resultsopen allclose all
Irritation parameter:
other: Mean maximum corneal swelling at up to 75 min
Run / experiment:
Mean of 3 replicates (%)
Value:
1.7
Vehicle controls validity:
not applicable
Negative controls validity:
valid
Positive controls validity:
valid
Remarks:
Mean corneal swelling: 8.7%
Remarks on result:
other: ICE CLASS I
Irritation parameter:
other: Mean maximum corneal swelling at up to 240 min
Run / experiment:
Mean of 3 replicates (%)
Value:
1.1
Vehicle controls validity:
not applicable
Negative controls validity:
valid
Positive controls validity:
valid
Remarks:
Mean corneal swelling: 20.7%
Remarks on result:
other: ICE CLASS I
Irritation parameter:
other: Mean maximum corneal opacity change
Run / experiment:
Mean of 3 replicates
Value:
0.17
Vehicle controls validity:
not applicable
Negative controls validity:
valid
Positive controls validity:
valid
Remarks:
Cornea Opacity: 4.00
Remarks on result:
other: ICE CLASS I
Irritation parameter:
other: Mean fluorescein retention change
Run / experiment:
Mean of 3 replicates
Value:
0.33
Vehicle controls validity:
not applicable
Negative controls validity:
valid
Positive controls validity:
valid
Remarks:
Fluorescein retention: 3.00
Remarks on result:
other: ICE CLASS I
Other effects / acceptance of results:
For detailed results see "attached full study report".
See table 8 and 9 for interpretation of the obtained results according to the UN GHS classification scheme and the scheme of Schutte et al (2009), Regulatory Toxicology and Pharmacology 54.

ACCEPTANCE OF RESULTS:
The results from all eyes used met the quality control standards. The negative control and positive control results were within the historical data range. This study was considered to be valid.

Any other information on results incl. tables

Table 8. SUMMARY TABLE FOR UN GHS CLASSIFICATION

Criteria for “No category” (all true)

 

3 endpoints classed as I or 2 endpoints classed as I and 1 endpoint classed as II or 1 endpoint classed as I and 2 endpoints classed as II:

True

No severe corneal morphological changes:

True

Test item was not stuck to the cornea at 240 minutes after the posttreatment rinse:

True

 

Criteria for “Category 1” (one or more true)

 

2 or more endpoints classed as IV:

False

Corneal opacity ≥ 3 at 30 min (in at least 2 eyes):

False

Corneal opacity = 4 at any time point (in at least 2 eyes):

False

Severe loosening of epithelium (in at least 1 eye):

False

 

Criteria for “No prediction can be made” (one or two true)

 

Based on the endpoints not classifiable for No Category, or for Category 1:

False

Particles of test item were stuck to the cornea and could not be washed off during the study:

False


Table 9. SUMMARY TABLE FOR SCHUTTE et al (2009) CLASSIFICATION

 

Criteria for “Not irritating” (all true)

 

3 endpoints classed as I or 2 endpoints classed as I and 1 endpoint classed as II 

True

No severe corneal morphological changes:

True

Test item was not stuck to the cornea at 240 minutes after the posttreatment rinse:

True

 

Criteria for “Severely irritating”, corresponding to UN GHS Category 1 (one or more true)

 

2 or more endpoints classed as IV:

False

Corneal opacity ≥ 3 at 30 min (in at least 2 eyes):

False

Corneal opacity = 4 at any time point (in at least 2 eyes):

False

Severe loosening of epithelium (in at least 1 eye):

False

 

Criteria for “Slightly irritating”, corresponding to UN GHS Category 2B (both true)

 

Not meeting the criteria for “Not irritating”, or for Category 1:

False

3 endpoints classed as II or 2 endpoints classed as II and 1 endpoint classed as I or 1 endpoint classed as I and 1 endpoint classed as II and 1 endpoint classed as III or 2 endpoints classed as II and 1 endpoint classed as III or 2 endpoints classed as I and 1 endpoint classed as IV.

False

 

Criteria for “Moderately irritating”, corresponding to UN GHS Category 2A (both true)

 

Not meeting the criteria for “Not irritating”, or for Category 1:

False

3 endpoints classed as III or 2 endpoints classed as III and 1 endpoint classed as II or 2 endpoints classed as III and 1 endpoint classed as IV or 2 endpoints classed as III and 1 endpoint classed as I or 2 endpoints classed as II and 1 endpoint classed as IV or 1 endpoint classed as II and 1 endpoint classed as III and 1 endpoint classed as IV.

False

Applicant's summary and conclusion

Interpretation of results:
other: No an eye irritant in accordance with EU CLP (EC no 1272/2008 and its amendments)
Conclusions:
The substance is not an eye irritant in the Isolated Chicken Eye Test (OECD guideline 438).
Executive summary:

An Isolated Chicken Eye Test (ICET) was performed with the Substance according to OECD guideline 438 and in accordance with GLP principles. Thirty µL of the Substance was applied to corneas (n=3). After 10 seconds exposure time, the surface of the eyes was rinsed with physiological saline solution. No significant corneal swelling change (mean = 1.1%) was observed during the four-hour observation period on test item treated eyes. No significant cornea opacity change (severity 0.5 on one eye and no cornea opacity change on two eyes) was observed. No significant fluorescein retention change (severity 0.5 on two eyes and no fluorescein retention change on one eye) was noted. No other morphological effect was observed. The negative control and positive control results were within the historical data range. It was therefore concluded that the test conditions were adequate and that the test system functioned properly. Based on the results, the endpoints Corneal swelling, Corneal opacity and Fluorescein retention were assigned ICE CLASS I and the substance is therefore not irritating to eyes.